Drug Type Peptide Conjugate Radionuclide, Therapeutic radiopharmaceuticals |
Synonyms nectin-4(Zonsen Peplib Biotech), PL 052, PL052 |
Target |
Action modulators |
Mechanism nectin-4 modulators(Nectin-4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Transitional Cell Carcinoma | Preclinical | China | 29 Feb 2024 | |
| Solid tumor | Discovery | China | 01 Nov 2025 |





